Maxim Group Starts Inovio Pharmaceuticals (INO) at Buy
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.40 -1.41%
Rating Summary:
11 Buy, 5 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Rating Summary:
11 Buy, 5 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Join SI Premium – FREE
Earlier, Maxim Group initiated coverage on Inovio Pharmaceuticals (NYSE: INO) with a Buy. PT $1.00.
For an analyst ratings summary and ratings history on Inovio Pharmaceuticals click here. For more ratings news on Inovio Pharmaceuticals click here.
Shares of Inovio Pharmaceuticals closed at $0.64 yesterday.
For an analyst ratings summary and ratings history on Inovio Pharmaceuticals click here. For more ratings news on Inovio Pharmaceuticals click here.
Shares of Inovio Pharmaceuticals closed at $0.64 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BWS Financial Starts Twist Bioscience (TWST) at Sell, 'Insider selling activity picked up steam'
- TD Cowen Starts Faeth Therapeutics (FTH) at Buy
- Freedom Capital Starts Pulse Biosciences (PLSE) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maxim GroupSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
